Biomerica (BMRA) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Biomerica (BMRA) is Moderate Underperform.

The composite score behind that read is -0.21, weighing +0.05 of bullish evidence against -0.52 bearish.

Biomerica last closed at $1.84, -2.65% on the session.

Against the IVW growth benchmark the position is -3.45% over the forecast window.

The read is built from 15 underlying insights — 1 bullish and 14 bearish.

Agreement across those insights is 93%.

20 graded predictions for BMRA so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Biomerica in the 11th percentile on return on equity, where 100 is best.

Biomerica is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $8.69M.

StockMap tracks Biomerica as the 134th largest of the 140 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 122 Neutral, 16 Moderate Underperform and 2 Moderate Outperform.

On that composite Biomerica ranks 124th of 140 in the group, against a group median of -0.03.